Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472281 - 472300 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FA01) rituximab | TRUXIMA 10MG/ML INJ,VIL,50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Wegener Granulomatosis;Leukemia, Lymphocytic, Chronic, B-Cell;Microscopic Polyangiitis | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FA01) rituximab | TRUXIMA 10MG/ML INJ,VIL,50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Wegener Granulomatosis;Leukemia, Lymphocytic, Chronic, B-Cell;Microscopic Polyangiitis | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FA03) obinutuzumab | GAZYVA 1000MG/40ML (25MG/ML) | 40ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L01FA03) obinutuzumab | GAZYVA 1000MG/40ML (25MG/ML) | 40ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L01FB01) inotuzumab ozogamicin | BESPONSA 0.9MG/VIL INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | Pfizer,Inc. |
| USA | (L01FB01) inotuzumab ozogamicin | BESPONSA 0.9MG/VIL INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | Pfizer,Inc. |
| USA | (L01FC01) daratumumab | DARZALEX 100MG/5ML INJ SOLN | 1X5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 100MG/5ML INJ SOLN | 1X5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX FASPRO 120MG/2000UNIT INJ SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX FASPRO 120MG/2000UNIT INJ SOLN | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC02) isatuximab | SARCLISA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FC02) isatuximab | SARCLISA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FC02) isatuximab | SARCLISA | 25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FC02) isatuximab | SARCLISA | 25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiAventisU.S.LLC |
| USA | (L01FD01) trastuzumab | HERCEPTIN HYLECTA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERCEPTIN HYLECTA | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
Pages
